WASHINGTON, July 22 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Alembic Pharmaceuticals Ltd. from its Center for Drug Evaluation and Research:

* * *

Recipient: Pratik Doshi, M.D., Alembic Pharmaceuticals Ltd., Alembic Research Centre Bioequivalence Facility, Alembic Road, Next to Bhailal Amin General Hospital Gorwa, Vadodara 390003, Gujarat, India

Issuing Office: Center for Drug Eva . . .

Click here for more information about our products